3rd Annual Clinical Trials and Drug Development in Pain Therapeutics

Venue: Loews L\'Enfant Plaza Hotel

Location: Washington, District Of Columbia, United States

Event Date/Time: Nov 11, 2002 End Date/Time: Nov 13, 2002
Report as Spam


The Institute for International Research (IIR) is proud to present its 3rd Annual Clinical Trials and Drug Development in Pain Therapeutics. This forum provides you with a unique opportunity to discuss strategies and discover solutions in overcoming challenges in analgesic product development and expediting clinical trials. The mission of this comprehensive event is to:

Integrate pharmacogenomics/pharmacogenetics in optimizing
target validation
Provide strategies in making better go/no-go decision, in analgesic product development
Overcome challenges in measuring clinical trial outcomes
More specifically, this conference addresses how to:

Leverage existing knowledge of known compounds to shorten the pain product development cycle
Understand how to assess and adopt innovations such as pharmacogenomics into product development
Examine exposure-response analysis to facilitate effective development process
Discuss the implications of addiction in pain therapeutics
Explore novel mediators of acute and chronic pain
Administer strategies to optimize clinical trials and enhance outcome measures
Integrate PK/PD principles into your development plan
Incorporate genetic association studies into lead optimization in analgesic development
Implement sound proof-of-concept for better decision-making
Understand the challenges in assessing and measuring pain in children
Assess the causes of failed pain studies and determine appropriate action